November 19, 2019
| Press Release
Rheonix Inc. Files 510(k) Seeking FDA Clearance of Triplex Sexually Transmitted Infection Assay
Rheonix files its first 510(k) on November 4, seeking to gain FDA clearance of its Rheonix STI TriPlex™ Assay
November 6, 2019
Rheonix to Exhibit at AMP 2019 Expo and host Corporate Workshop on automated and integrated NGS OnePrep™ Solution.